MBX MBX Biosciences, Inc.
Company Analysis
Latest News
🔴 MBX Biosciences is trading 4% down today with no clear company-specific catalyst
MBX Biosciences is trading 4.03% down at $60.38 after no clear company-specific negative catalyst emerged on September 21, 2026. - Recent coverage highlights...
🟢 MBX Biosciences rises 5.0% — Biotech Sector Rallies on Strong Industry Outlook and M&A Optimism
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🔴 MBX Biosciences is trading 4.3% down today amid geopolitical risk and hawkish Fed expectations
MBX Biosciences is trading at $60.30 (-4.29%) as broader markets decline amid rising geopolitical risk, oil prices, and hawkish Federal Reserve...
🔴 MBX Biosciences falls 4.4% — Biotech Sector Declines Amid Fed Rate Hike Fears
With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
MBX Biosciences Doses First Patient in Pivotal Phase 3 Hypoparathyroidism Trial
MBX Biosciences announced it has dosed the first patient in its pivotal Phase 3 clinical trial, named "oPTimize," for its drug candidate canvuparatide. The...
🟢 MBX Biosciences is trading 4.5% up today
MBX Biosciences is trading 4.5% up at $69.37, while the direct catalyst remains unclear. - No new company-specific announcement dated August 25, 2026 was...
MBX Biosciences Rated Overweight at JPMorgan, Citing $88 Obesity Pipeline Target
JPMorgan resumed coverage of MBX Biosciences with an Overweight rating. The investment bank established a price target of $88 per share. Analyst Jessica Fye...
🔴 MBX Biosciences falls 4.1% — Biotech Sector Cools Off After Moderna-Sparked Rally
With Biotech (XBI) down 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a pullback after a...
MBX Biosciences PT Raised to $88 at Truist, Driven by Obesity Data
Truist Securities raised its price target for MBX Biosciences, Inc. to $88 from $70. The investment firm reiterated its Buy rating on the stock. This new...
MBX Biosciences Surges 10% on Earnings Anticipation — But Can a Cash-Burning Biotech With No Revenue Justify the Optimism?
Shares of MBX Biosciences jumped 10% to $70.88 on August 7 as investors piled in ahead of what turned out to be the company's Q2 2026 earnings release —...
🔴 MBX Biosciences is trading 4% down today as traders reposition ahead of Q2 earnings
MBX Biosciences is trading at $67.87 (4% down) as traders reposition ahead of its Q2 2026 earnings report scheduled for August 06, 2026. • Analysts expect the...
MBX Biosciences, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 06, 2026
MBX Biosciences is projected to report no revenue and a consensus loss of $0.63 per share for Q2 2026, with the current $69.52 share price trading below the...
🟢 MBX Biosciences is trading 10.1% up today ahead of earnings and amid sector strength
MBX Biosciences is trading 10.1% up now at $70.88 as traders position ahead of its upcoming earnings report, expected around August 5–6, 2026. • Investor...
🟢 MBX Biosciences is trading 4.1% up today ahead of earnings and broader market strength
MBX Biosciences is trading at $67.03, up 4.1% today, as investors position ahead of its upcoming earnings report and amid broader market strength. • The...
🟢 MBX Biosciences is trading 4% up today amid a sector-wide biotech and market rally
MBX Biosciences is trading at $66.54 (up 4%), moving in line with a strong rebound in growth stocks and biotech peers rather than any fresh company-specific...
🟢 MBX Biosciences is trading 4.13% up today amid broader risk-on sentiment and higher Nasdaq futures
MBX Biosciences is trading at $66.60 (+4.13%) in pre-market sessions, appearing to move in tandem with a broader market rebound rather than specific corporate...
🟢 MBX Biosciences is trading 4.1% up today on a modest intraday rebound
MBX Biosciences is trading at $62.53 (+4.11%) on a modest intraday rebound despite a lack of company-specific catalysts or regulatory updates. • No major...
🟢 MBX Biosciences is trading 5.3% up
MBX Biosciences is trading at $61.40, up 5.3% from a comparison close of $58.30 during regular trading. This is a price-action follow-up, so a separate...
🔴 MBX Biosciences is trading 5.0% down
MBX Biosciences is trading at $57.26, down 5.0% from a comparison close of $60.28 during regular trading. This is a price-action follow-up, so a separate...
🔴 MBX Biosciences is trading 4.2% down today following a downgrade to "Sell" by Wall Street Zen
MBX Biosciences is trading at $60.27 (down 4.2%) today. The decline follows a downgrade by Wall Street Zen from a "hold" to a "sell" rating issued on...